Update on HPV: Beyond cervical cancer
1.0 CME Credits
Symposium held November 2008 at the American Society for Reproductive Medicine Annual Meeting in San Francisco, California. Supported by an independent educational grant from Merck and Co., Inc.
Joel Palefsky, MD
University of California
Division of Infectious Diseases
San Francisco, California
VIEW WEBCAST | TRANSCRIPT
Hope K. Haefner, MD
University of Michigan
Ann Arbor, Michigan
VIEW WEBCAST | TRANSCRIPT
Click here for an exclusive recap from Dr Haefner: HPV and the vulva and vagina
J.Thomas Cox, MD
University of California Santa Barbarba
Santa Barbara, California
VIEW WEBCAST | TRANSCRIPT
Click here for an exclusive recap from Dr Cox: HPV viruses and vaccines: FAQs to expect from patients
Educational Objectives?
At the end of this symposium, attendees will be able to:
- Describe the mechanism of HPV-induced oncogenesis and the data to date on the prevention of cervical precancer (CIN3 and AIS) though HPV vaccination.
- Discuss the burden of HPV associated cancers of the penis, anus and oral pharynx (including respiratory papillomatosis) and the data on primary prevention by HPV vaccination of HPV infection and precancer in these areas.
- Describe the burden of HPV associated benign genital warts, vulvar intraepithelial neoplasia (VIN), vaginal intraepithelial neoplasia (VAIN) and cancers of the vulva and vagina and the data on primary prevention by HPV vaccination.
Accreditation Statement
The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement?
The American Society for Reproductive Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
It is the policy of the ASRM to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. All faculty/authors participating in this activity are expected to disclose any relationships they may have with companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. The content and views presented in this activity are those of the faculty/authors and do not necessarily reflect those of the ASRM or Merck and Co., Inc. Any discussion of off-label, experimental, or investigational use of drugs or devices will also be disclosed. The disclosure statements were reviewed by the Subcommittee for Standards of Commercial Support of the CME Committee of ASRM and any perceived conflicts of interest were resolved in accordance with the policies of the ACCME.
Disclosure
J. Thomas Cox, MD reports that he serves on the scientific advisory boards of Gen-Probe, Takeda, Diamics, and Tigris Pharmaceuticals. He also serves on the advisory board for Graceway Pharmaceuticals and Merck HPV Vaccine Data and Safety Monitor.
Joel Palefsky, MD reports that he receives Research Grant Support from Merck and Co. and serves on the advisory board of GSK.
Hope K. Haefner, MD reports she serves a speaker for Merck and Co. Inc., and serves as a consultant for Datamonitor.
There may be discussion of off-label or otherwise nonapproved uses of products and/or devices.
Acknowledgments
Sponsored by the American Society for Reproductive Medicine.
Supported by an educational grant from Merck & Co., Inc.
Click here for free CME TEST
|
